We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CVS Health (CVS - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
CVS Health is one of 983 companies in the Medical group. The Medical group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 3.8% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, CVS has returned 33.7% so far this year. Meanwhile, the Medical sector has returned an average of -5.1% on a year-to-date basis. As we can see, CVS Health is performing better than its sector in the calendar year.
Another stock in the Medical sector, Agenus (AGEN - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 114.6%.
For Agenus, the consensus EPS estimate for the current year has increased 141.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, a group that includes 58 individual stocks and currently sits at #89 in the Zacks Industry Rank. This group has lost an average of 5.7% so far this year, so CVS is performing better in this area.
In contrast, Agenus falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 492 stocks and is ranked #91. Since the beginning of the year, the industry has moved +1%.
Investors interested in the Medical sector may want to keep a close eye on CVS Health and Agenus as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CVS Health (CVS - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
CVS Health is one of 983 companies in the Medical group. The Medical group currently sits at #7 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 3.8% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, CVS has returned 33.7% so far this year. Meanwhile, the Medical sector has returned an average of -5.1% on a year-to-date basis. As we can see, CVS Health is performing better than its sector in the calendar year.
Another stock in the Medical sector, Agenus (AGEN - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 114.6%.
For Agenus, the consensus EPS estimate for the current year has increased 141.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, a group that includes 58 individual stocks and currently sits at #89 in the Zacks Industry Rank. This group has lost an average of 5.7% so far this year, so CVS is performing better in this area.
In contrast, Agenus falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 492 stocks and is ranked #91. Since the beginning of the year, the industry has moved +1%.
Investors interested in the Medical sector may want to keep a close eye on CVS Health and Agenus as they attempt to continue their solid performance.